Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Gilead Sciences, Inc. (GILD) had Current Ratio of 1.38 for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$8.30B |
|
$2.43B |
|
$1.57B |
|
$6.73B |
|
$4.84B |
|
$3.46B |
|
$-399.00M |
|
$3.06B |
|
$3.06B |
|
$2.43B |
|
$2.43B |
|
$2.43B |
|
$2.43B |
|
$3.46B |
|
$4.20B |
|
1.24B |
|
1.25B |
|
$1.96 |
|
$1.94 |
|
| Balance Sheet Financials | |
$16.55B |
|
$5.95B |
|
$34.85B |
|
$51.41B |
|
$12.00B |
|
$23.82B |
|
$26.45B |
|
$38.45B |
|
$12.95B |
|
$-8.78B |
|
$12.96B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$11.15B |
|
$-8.82B |
|
$-3.42B |
|
$7.56B |
|
$6.44B |
|
$-1.13B |
|
$683.00M |
|
$-3.11B |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.38 |
-- |
|
-- |
|
0.65 |
|
2.02 |
|
81.07% |
|
41.71% |
|
41.71% |
|
-- |
|
36.90% |
|
29.27% |
|
$10.66B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.83 |
|
1.66 |
|
54.29 |
|
18.75% |
|
-27.66% |
|
4.72% |
|
6.61% |
|
$10.44 |
|
$8.52 |
|
$8.91 |
|